Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Jaguar Health (JAGX) FCF Margin (2016 - 2025)

Jaguar Health (JAGX) has disclosed FCF Margin for 11 consecutive years, with 169.24% as the latest value for Q4 2025.

  • Quarterly FCF Margin rose 5378.0% to 169.24% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 205.66% through Dec 2025, up 4573.0% year-over-year, with the annual reading at 206.12% for FY2025, 4539.0% up from the prior year.
  • FCF Margin for Q4 2025 was 169.24% at Jaguar Health, down from 152.09% in the prior quarter.
  • The five-year high for FCF Margin was 55.57% in Q4 2022, with the low at 38475.0% in Q1 2022.
  • Average FCF Margin over 5 years is 3862.17%, with a median of 312.11% recorded in 2023.
  • The sharpest move saw FCF Margin tumbled -1812955bps in 2022, then surged 3795891bps in 2023.
  • Over 5 years, FCF Margin stood at 417.94% in 2021, then skyrocketed by 87bps to 55.57% in 2022, then plummeted by -483bps to 323.96% in 2023, then soared by 31bps to 223.03% in 2024, then increased by 24bps to 169.24% in 2025.
  • According to Business Quant data, FCF Margin over the past three periods came in at 169.24%, 152.09%, and 207.89% for Q4 2025, Q3 2025, and Q2 2025 respectively.